Enanta Pharmaceuticals, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 9EP.F | ASMB | AVIR | EDSA | TRDA | IVVD | |
|---|---|---|---|---|---|---|
| Market cap | 266.50M | 404.57M | 357.71M | 29.32M | 197.02M | 186.76M |
| P/E (TTM) | — | 19.1 | — | — | — | — |
| Forward P/E | -1.7 | -7.7 | -3.0 | — | -1.6 | -1.2 |
| Price/book | 3.0 | 1.3 | 1.8 | 52.9 | 0.8 | 1.0 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +2.73% | −36.33% | +37.23% | +27.65% | −31.99% | −61.71% |
| Today | −2.66% | −0.25% | +6.95% | −4.82% | +7.20% | +8.96% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All 9EP.F news ›Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2026
Fiscal Third Quarter Ended June 30, 2026 Financial Results Research and development expenses totaled $22.1 million for the three months ended June 30, 2026, compared to $27.2 million for the three months ended June 30, 2025. The decrease…
Enanta Pharmaceuticals Announces Advancement of its Zelicapavir Clinical Development Program for the Treatment of Respiratory Syncytial Virus (RSV)
Registrational Ph2b/3 Trial of Zelicapavir to Initiate in High-Risk Adults with RSV in 4Q 2026, with Topline Phase 2b Data Expected in 2027 Phase 2b Trial of Zelicapavir to Initiate in Pediatric Patients with RSV in 3Q 2026, with Topline…
Enanta Pharmaceuticals to Present Data for Zelicapavir, an Oral, Once-Daily, N-Protein Inhibitor, in Development for the Treatment of Respiratory Syncytial Virus, at IDWeek™ 2026
BioSpace Enanta Pharmaceuticals to Present Data for Zelicapavir, an Oral, Once-Daily, N-Protein Inhibitor, in Development
Enanta Pharmaceuticals (NASDAQ:ENTA) Upgraded at Wall Street Zen
Posted by Sarita Garza on Oct 6th, 2026 Wall Street Zen upgraded shares of Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) from a sell rating to a hold rating in a report published on Saturday,Wall Street Zen reports. Get Our Latest…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- ir.enanta.com1
- stocktitan.net1
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.